Home|Journals|Articles by Year|Audio Abstracts
 

Review Article



Polio Vaccination in Nigeria: The ‘good’, the ‘bad’ and the ‘ugly’

MM Baba, Michael Ayivor.




Abstract

With increase in the number of polio cases, Nigeria serves as the primary threat to a polio free world. The “good” the bad” and “the ugly” aspects of polio vaccination in Nigeria is discussed. In the ‘good’ aspect the number of wild poliovirus cases declined by over 90%, cVDPV 2 cases declined by 82%. Similarly, genetic clusters of both wild poliovirus type 1 and type 3 have re-duced form 18 and 19 in 2009 to 2 respectively. The Immunity to polioviruses has improved in endemic States and new approaches for better identification of settlements and to promote com-munity participation have been adopted in 2012. On the ‘bad ‘aspect, polio cases have increased from 21 in 2010 to 62 in 2011 and 84 in 2012(7th September) with ongoing transmission of wild poliovirus type1, 3 and cVDPV2. Declined political oversight at critical juncture and non Im-plementation of emergency plans in key infected areas has been observed. Non-compliance to the vaccine seems to be the major contributor to the increasing number of polio cases in the country. Lastly “the ugly” face focuses on the aftermath of the boycott of polio vaccination in northern States in 2003 amidst the rumor that the vaccine contained infertility drugs, causes poli-omyelitis and spread HIV. After resolving the crisis, some parents in the north still resist com-pliance with the polio vaccination. Borrowing a leave from the rally organized by the polio vic-tims, all Nigerians should complement the government efforts in ‘kicking’ polio out of the coun-try.

Key words: Polio vaccination; wild polio virus; Immunization plus Days; Micro Planning, Nigeria






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.